# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001367644-24-000060
Filing Date
2024-05-01
Accepted
2024-05-01 16:44:14
Documents
60
Period of Report
2024-04-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | ebs-20240429.htm iXBRL | 8-K | 33495
2 | EX-10.1 | acam_75a50119c00071xmod1.htm | EX-10.1 | 29159
3 | EX-99.1 | ebs2024-03x31ex99earningsr.htm | EX-99.1 | 490546
4 | EX-99.2 | ebs2024-03x31deckfinalv2.htm | EX-99.2 | 50236
9 |  | acam_75a50119c00071xmod1001.jpg | GRAPHIC | 250240
10 |  | acam_75a50119c00071xmod1002.jpg | GRAPHIC | 198239
11 |  | acam_75a50119c00071xmod1003.jpg | GRAPHIC | 251693
12 |  | acam_75a50119c00071xmod1004.jpg | GRAPHIC | 210116
13 |  | acam_75a50119c00071xmod1005.jpg | GRAPHIC | 234153
14 |  | acam_75a50119c00071xmod1006.jpg | GRAPHIC | 257078
15 |  | acam_75a50119c00071xmod1007.jpg | GRAPHIC | 194707
16 |  | acam_75a50119c00071xmod1008.jpg | GRAPHIC | 28770
17 |  | acam_75a50119c00071xmod1009.jpg | GRAPHIC | 197171
18 |  | acam_75a50119c00071xmod1010.jpg | GRAPHIC | 92771
19 |  | ebs2024-03x31deckfinalv2001.jpg | GRAPHIC | 79525
20 |  | ebs2024-03x31deckfinalv2002.jpg | GRAPHIC | 66764
21 |  | ebs2024-03x31deckfinalv2003.jpg | GRAPHIC | 283036
22 |  | ebs2024-03x31deckfinalv2004.jpg | GRAPHIC | 53965
23 |  | ebs2024-03x31deckfinalv2005.jpg | GRAPHIC | 74687
24 |  | ebs2024-03x31deckfinalv2006.jpg | GRAPHIC | 121672
25 |  | ebs2024-03x31deckfinalv2007.jpg | GRAPHIC | 81971
26 |  | ebs2024-03x31deckfinalv2008.jpg | GRAPHIC | 69751
27 |  | ebs2024-03x31deckfinalv2009.jpg | GRAPHIC | 102351
28 |  | ebs2024-03x31deckfinalv2010.jpg | GRAPHIC | 68940
29 |  | ebs2024-03x31deckfinalv2011.jpg | GRAPHIC | 93364
30 |  | ebs2024-03x31deckfinalv2012.jpg | GRAPHIC | 72023
31 |  | ebs2024-03x31deckfinalv2013.jpg | GRAPHIC | 124707
32 |  | ebs2024-03x31deckfinalv2014.jpg | GRAPHIC | 79745
33 |  | ebs2024-03x31deckfinalv2015.jpg | GRAPHIC | 132299
34 |  | ebs2024-03x31deckfinalv2016.jpg | GRAPHIC | 102633
35 |  | ebs2024-03x31deckfinalv2017.jpg | GRAPHIC | 100127
36 |  | ebs2024-03x31deckfinalv2018.jpg | GRAPHIC | 99816
37 |  | ebs2024-03x31deckfinalv2019.jpg | GRAPHIC | 111184
38 |  | ebs2024-03x31deckfinalv2020.jpg | GRAPHIC | 90983
39 |  | ebs2024-03x31deckfinalv2021.jpg | GRAPHIC | 84772
40 |  | ebs2024-03x31deckfinalv2022.jpg | GRAPHIC | 253252
41 |  | ebs2024-03x31deckfinalv2023.jpg | GRAPHIC | 23489
42 |  | ebs2024-03x31deckfinalv2024.jpg | GRAPHIC | 69996
43 |  | ebs2024-03x31deckfinalv2025.jpg | GRAPHIC | 78452
44 |  | ebs2024-03x31deckfinalv2026.jpg | GRAPHIC | 75462
45 |  | ebs2024-03x31deckfinalv2027.jpg | GRAPHIC | 128894
46 |  | ebs2024-03x31deckfinalv2028.jpg | GRAPHIC | 40629
47 |  | ebs2024-03x31deckfinalv2029.jpg | GRAPHIC | 70119
48 |  | ebs2024-03x31deckfinalv2030.jpg | GRAPHIC | 58819
49 |  | ebs2024-03x31deckfinalv2031.jpg | GRAPHIC | 84989
50 |  | ebs2024-03x31deckfinalv2032.jpg | GRAPHIC | 23677
51 |  | emergentlogograycarminera.jpg | GRAPHIC | 75656
| Complete submission text file | 0001367644-24-000060.txt |  | 7706221

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ebs-20240429.xsd | EX-101.SCH | 2220
6 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | ebs-20240429_def.xml | EX-101.DEF | 15328
7 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | ebs-20240429_lab.xml | EX-101.LAB | 27218
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | ebs-20240429_pre.xml | EX-101.PRE | 16030
63 | EXTRACTED XBRL INSTANCE DOCUMENT | ebs-20240429_htm.xml | XML | 2722

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 24903725
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)